54 filings
8-K
XGN
Exagen Inc
13 May 24
Results of Operations and Financial Condition
8:00am
8-K
XGN
Exagen Inc
26 Apr 24
Exagen Inc. Announces Changes to the Board of Directors
8:32am
8-K
XGN
Exagen Inc
18 Mar 24
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
8:00am
8-K
XGN
Exagen Inc
8 Jan 24
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
8:00am
8-K
XGN
Exagen Inc
11 Dec 23
Departure of Directors or Certain Officers
4:05pm
8-K
fvitv4
17 Nov 23
Entry into a Material Definitive Agreement
4:30pm
8-K
fzetjgm oy4
13 Nov 23
Exagen Inc. Reports Strong Third Quarter 2023 Results
4:05pm
8-K
a5kxmi qer4
26 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
j5jsmjr2slkn1tvlv
7 Aug 23
Exagen Inc. Reports Strong Second Quarter 2023 Results
8:00am
8-K
qkw4bk
24 Jul 23
Exagen Inc. Appoints Paul Kim to Board of Directors
4:05pm
8-K
c2cqbdjx
14 Jun 23
Submission of Matters to a Vote of Security Holders
4:50pm
8-K
t9mn hdjojw
15 May 23
Exagen Inc. Reports First Quarter 2023 Results
4:05pm
8-K
nzwx34jy56c
4 May 23
Entry into a Material Definitive Agreement
9:00am
8-K
0rvwh ucvn
23 Mar 23
Departure of Directors or Certain Officers
9:00am
8-K
62q0w vcmlu1uq6vbz
20 Mar 23
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
4:05pm
8-K
6b9vfijysuzrjhisy
23 Jan 23
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
9:00am
8-K
ejp2kdfdhbxh
9 Jan 23
Results of Operations and Financial Condition
9:00am
8-K
63zohlitdsv17n jbg3
5 Dec 22
Cost Associated with Exit or Disposal Activities
4:22pm
8-K
idpzsocfh9ae1o 4p70
14 Nov 22
Exagen Inc. Reports Third Quarter 2022 Results
4:08pm
8-K
g6v 135ksva6
20 Oct 22
Exagen Announces Appointment of John Aballi as CEO
4:05pm